ReviewFrontiers in immunology2013

CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines.

Annalisa Ciabattini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.